CALR and cancer: ICD is characterized by an alteration in the levels of calreticulin (CRT) in the plasma membrane of cancer cells [7] and the release of damage-associated molecular pattern (DAMP) molecules, such as ATP and high mobility group B1 (HMGB1), from dying cancer cells [1,8].